sch 28080 has been researched along with calcimycin in 2 studies
Studies (sch 28080) | Trials (sch 28080) | Recent Studies (post-2010) (sch 28080) | Studies (calcimycin) | Trials (calcimycin) | Recent Studies (post-2010) (calcimycin) |
---|---|---|---|---|---|
217 | 0 | 20 | 11,946 | 40 | 444 |
Protein | Taxonomy | sch 28080 (IC50) | calcimycin (IC50) |
---|---|---|---|
XBP1 | Homo sapiens (human) | 1.41 | |
DNA damage-inducible transcript 3 protein | Mus musculus (house mouse) | 0.16 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
ChacĂn, J; Lobo, P; Subero, O | 1 |
Hibino, T; Ishii, Y; Levin, M; Nishino, A | 1 |
2 other study(ies) available for sch 28080 and calcimycin
Article | Year |
---|---|
Ca2+ requirement for metabolic effects of secretagogues in the amphibian gastric mucosa.
Topics: Acetates; Animals; Anti-Ulcer Agents; Bufo marinus; Butyrates; Butyric Acid; Calcimycin; Calcium; Gastric Juice; Gastric Mucosa; Glycogen; Histamine; Imidazoles; In Vitro Techniques; Kinetics; Omeprazole; Oxygen Consumption; Potassium; Theophylline | 1989 |
Ion flow regulates left-right asymmetry in sea urchin development.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Body Patterning; Calcimycin; Dose-Response Relationship, Drug; Embryo, Nonmammalian; Embryonic Development; Enzyme Inhibitors; Gene Expression Regulation, Developmental; Imidazoles; Ionophores; Ions; Lansoprazole; Omeprazole; Proton Pump Inhibitors; Sea Urchins | 2006 |